https://rjrindex.com/articles/a-pilot-study-exploring-four-meditation-practices-for-anxiety-among-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-per-patient-per-month-for-a-median-of-3-months-real-world-value-signals-of-kras 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-malnutrition-and-morbid-obesity-on-inpatient-mortality-among-patients-with-hematologic-mal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-late-phase-randomized-open-label-multi-cohort-trial-to-evaluate-immune-related-adverse-events-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-neoadjuvant-chemotherapy-reduce-axillary-lymph-node-dissection-in-postmenopausal-erher2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-to-transplant-by-sociodemographic-group-following-meld-30-implementation-in-hepatocellular-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-donafenib-plus-anti-pd-1-therapy-in-hepatocellular-carcinoma-with-high-risk-features-after 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-patterns-and-temporal-trends-of-colorectal-cancer-burden-in-older-adults-aged-70-years 2026-08-24 monthly 0.7 https://rjrindex.com/articles/maintenance-liposomal-doxorubicin-following-induction-doxorubicin-in-soft-tissue-sarcoma-a-single-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-germline-genetic-testing-rates-among-newly-diagnosed-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-for-low-income-patients-with-early-onset-colorectal-cancer-an-analysis-of-the-nat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-experience-of-home-based-oncology-care-among-privately-funded-uk-based-patients-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-febrile-neutropenia-with-colony-stimulating-factors-a-multicenter-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-correlates-of-patient-provider-communication-and-financial-toxicity-in-black-and-white-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/end-of-life-care-quality-indicators-in-advanced-cancer-patients-at-a-brazilian-tertiary-hospital 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-cutaneous-diffuse-large-b-cell-lymphoma-leg-type-a-systematic-review-of-morphological-mimi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-alternative-dosing-strategies-for-fda-approved-oncology-biologics-based-on-reanalysis-of-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comorbidities-and-concomitant-medication-use-in-patients-with-tki-naive-advanced-or-metastatic-alk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hematologic-malignancies-to-define-a-distinct-high-risk-sepsis-phenotype-among-hospitalized-cancer-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-utilization-and-inpatient-outcomes-of-minimally-invasive-colectomy-for-colorectal-cancer-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-objective-response-of-kras-g12c-inhibitors-versus-docetaxel-in-previously-treated-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elevate-empowered-social-media-coaching-for-oncologists 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-academic-multimodal-ctdna-strategy-for-minimal-residual-disease-detection-and-therapy-monitoring 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-breast-cancer-located-in-the-upper-outer-quadrant-uoq-and-axillary-lymph-node 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triple-negative-oligometastatic-breast-cancer-a-retrospective-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-sequencing-after-adjuvant-treatment-failure-in-patients-with-melanoma-a-retrospective-coh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-safety-and-efficacy-of-sys6010-combined-with-enlonstobart-in-patients-with-recurrent-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-lung-cancer-and-hypertension-related-mortality-in-the-united-states-1999 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-cannabis-use-on-relapse-and-remission-rates-in-patients-with-acute-lymphoblastic-leukem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-spectrum-and-her2msi-biomarker-status-in-gastric-adenocarcinoma-a-tertiary-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rural-urban-disparities-in-chemotherapy-administration-and-quality-certifications-in-minnesota 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-trifluridine-tipiracil-with-vegf-inhibitors-and-egfr-inhibitors-in-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-ai-prediction-of-head-and-neck-cancer-treatment-outcomes-with-whole-slide-imaging 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-based-total-neoadjuvant-therapy-versus-neoadjuvant-chemoradiotherapy-in-locally-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-serplulimab-plus-nab-paclitaxel-and-sox-in-locally-advanced-gastric-or-gastroesophageal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/laparoscopic-versus-open-distal-gastrectomy-for-clinical-t4a-gastric-cancer-short-term-outcomes-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-checkpoint-inhibitor-pneumonitis-associated-with-anti-angiogenic-agents-in-non-small-cell-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-germline-cancer-predisposition-pathogenic-variants-in-cancer-cohorts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/weekend-admission-and-inpatient-outcomes-in-hospitalized-patients-with-acute-promyelocytic-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-availability-and-quality-of-serious-illness-documentation-using-large-language-models 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-study-of-prolonged-administration-of-naxitamab-irinotecan-and-temozolomide-for-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omics-approaches-to-unveil-the-mixed-molecular-characteristics-of-hepatoid-adenocarcinoma-of-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-cardiac-lymphoma-mesothelioma-and-sarcoma-a-population-based-study-of-primary-malign 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-phase-1b2-study-results-of-purinostat-mesylate-pm-in-combination-with-pomalidomide-pom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ea6232-a-phase-ii-double-blind-trial-of-sulforaphane-for-therapeutic-prevention-of-melanoma-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hiv-lymphomas-in-the-safety-net-setting-a-decade-of-experience-at-a-single-institution 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-trifluridinetipiracil-plus-oxaliplatin-in-patients-with-advanced-or-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-improvement-enhancing-family-history-documentation-for-invasive-cancer-patients-in-a-commun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/re-evaluating-pathologic-response-as-a-surrogate-endpoint-after-neoadjuvant-immune-checkpoint-inhibi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/compartment-specific-spatial-transcriptomics-to-reveal-microenvironmental-programs-driving-omental-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-grouping-of-nut-carcinoma-within-a-cancer-family-context 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-of-the-leading-cancers-in-brazil-real-world-evidence-from-a-national-data-platform 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-cancer-mortality-among-individuals-with-substance-use-disorder-in-the-unit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-toxicity-outcomes-with-adjuvant-pembrolizumab-following-nephrectomy-for-renal-cell-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-adjusting-for-c-kit-exon-11-mutation-status-when-comparing-prognostic-models-for-gastr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-cdk46-inhibitor-re-treatment-in-hrher2-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-adolescent-and-young-adult-lung-cancer-in-south-asia-19902023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-timely-immunizations-on-infection-related-outcomes-after-cll-directed-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-surufatinib-combined-with-immune-checkpoint-inhibitors-plus-chemotherapy-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cumulative-low-dose-ionizing-radiation-exposure-in-frequent-emergency-department-encounters-and-impl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-capox-combined-with-traditional-chinese-medicine-tiaopi-anchang-decoction-on-disease-fre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-first-in-human-open-label-dose-escalation-and-expansion-study-of-tak-188-a-novel-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-randomized-open-label-study-of-incb123667-versus-investigators-choice-of-chemotherapy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-therapy-for-head-and-neck-squamous-cell-carcinoma-based-on-hyperprogression-genotyping 2026-08-24 monthly 0.7 https://rjrindex.com/articles/experiences-of-a-cancer-survivorship-elective-in-a-us-medical-school-the-first-10-years 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-plasma-based-epigenomic-profiling-from-intr-at-pid-lung-037-study-samples-to-identify-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-alkbh5-with-mefloquine-as-a-therapeutic-strategy-to-enhance-antitumor-immunity-in-osteosar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omics-discovery-and-clinical-validation-of-col1a2-alternative-splicing-isoforms-as-liquid-biop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-the-impact-of-igtf2ii-mutations-in-thymic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beta-blockers-and-overall-survival-in-men-receiving-adt-systemic-therapy-for-metastatic-prostate-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimization-of-tumor-infiltrating-lymphocyte-til-manufacturing-in-non-small-cell-lung-cancer-nsc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemo-immunotherapy-as-a-reshaper-of-immunosuppressive-activity-and-gene-expression-of-circulating-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-circulating-mir-30a-5p-and-mir-93-5p-as-liquid-biopsy-biomarkers-for-prediction-of-prognosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-physician-characteristics-and-likelihood-of-caring-for-underserved-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-centric-insights-a-single-center-analysis-of-clinical-presentation-treatment-approaches-and-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-genetic-ancestry-on-uv-mutational-signatures-linked-to-immunotherapy-response-in-melano 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-iii-trial-adjuvant-cd40hvac-an-immunotherapy-engaging-dendritic-cells-dc-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-axis-biomarker-model-integrating-kim-1-and-madcam-1-in-metastatic-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-palliative-care-utilization-and-outcomes-among-decedent-patients-with-metastatic-cancer-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-role-of-informal-caregivers-in-metastatic-cancer-patients-treated-with-oral-anticance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-remote-therapeutic-monitoring-on-time-to-discontinuation-and-acute-care-events-among-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathology-based-machine-learning-model-for-prediction-of-pathologic-complete-response-to-neoa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-discontinuation-of-sup177sup-lu-psma-617-after 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hampe-based-msimmr-testing-with-artificial-intelligence-in-colorectal-cancer-a-blinded-evaluatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-intravenous-biosimilar-pertuzumab-and-trastuzumab-versus-subcutaneous-pertuzumabtrastuz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-decision-impact-of-18f-psma-1007-petct-for-prostate-cancer-staging-avoiding-over-and-und 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-adverse-events-and-patient-outcomes-in-non-small-cell-lung-cancer-a-silver-lining 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-early-cachexia-in-metastatic-nsclc-a-nationwide-veterans-health-administrat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-l1-cps-10-population-subgroup-analysis-of-keynote-412-pembrolizumab-plus-chemoradiotherapy-vers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-and-geographic-disparities-in-early-onset-pancreatic-cancer-mortality-in-the-united 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-pathway-utilization-after-endoscopic-ultrasound-in-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitor-ici-toxicity-in-a-large-prospective-cohort-of-patients-with-solid-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-educational-and-research-gaps-among-young-oncologists-in-latin-america-results-from-a-mult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-role-of-gut-microbiota-and-their-metabolites-in-the-efficacy-of-immune-checkpoint-inhibit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-magnesium-level-and-survival-outcomes-in-extensive-stage-small-cell-lung-cancer-treated-with-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-peri-dose-high-sensitivity-troponin-on-clinically-significant-cardiac-events-and-il-2-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-performance-of-a-multimodal-artificial-intelligence-histopathology-based-tool-versus-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-genomic-characteristics-of-a-low-homologous-recombination-deficiency-score-subgroup-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographics-and-outcomes-of-individuals-with-young-onset-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-adherence-to-adjuvant-abemaciclib-among-patients-with-early-hormon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/amivantamab-in-hpv-unrelated-recurrentmetastatic-head-and-neck-squamous-cell-cancer-after-disease-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-ct-derived-qvt-score-as-predictor-of-bevacizumab-benefit-in-advanced-non-squamous-nsclc-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cytokine-dynamics-in-a-phase-ii-trial-of-metronomic-carboplatinpaclitaxel-combined-with-cemiplimab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-iron-supplementation-in-the-efficacy-of-immune-checkpoint-inhibitors-icis-a-real-world-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-based-methylation-profiling-of-molecular-breast-cancer-subtypes-mbs-in-hormone-receptor-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comprehensive-evaluation-of-the-effectiveness-of-the-geriatric-8-screening-tool-in-japanese-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mesenteric-approach-during-pancreaticoduodenectomy-as-modulator-of-ctc-dna-dynamics-in-pancreatic-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-a-pilot-feasibility-study-of-a-novel-community-health-worker-led-intervention-deliverin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-early-unfractionated-heparin-use-in-nstemi-patients-with-acute-leukemia-and-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vepdegestrant-a-proteolysis-targeting-chimera-protac-estrogen-receptor-er-degrader-plus-abemac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/yttrium-90-sirt-plus-atezolizumabbevacizumab-in-unresectable-huge-hcc-gt10-cm-a-multicenter-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-neo-epitope-based-vaccine-ose2101-with-or-without-pembrolizumab-versus-best-supportive-care-as-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-itp53i-mutated-myeloid-neoplasms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-modal-liquid-biopsy-integrating-cfdna-fragmentomics-and-serum-biomarkers-for-the-differential 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-inflammation-and-tumor-immune-microenvironment-biomarkers-foxp3-cd68-cd163-stratified-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sintilimab-pd-1-antibody-plus-gemcitabine-and-docetaxel-gt-as-first-line-or-later-line-therapy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/raceethnicity-stratified-survival-differences-associated-with-psychotropic-medication-use-in-pancre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rates-of-metachronous-colorectal-cancer-or-secondary-lynch-syndrome-related-cancers-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/percutaneous-cryoablation-for-the-treatment-of-extra-abdominal-desmoid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mental-health-and-malignancy-real-world-associations-between-early-onset-hormone-related-cancers-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-tocilizumab-in-resolving-chimeric-antigen-receptor-t-cell-car-t-induced-cytokine-relea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-treatment-effect-on-distant-recurrence-free-survival-from-functional-tumor-volume-change 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-her2-blockade-with-or-without-taxane-induction-in-hrher2-metastatic-breast-cancer-a-compara 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alrizomadlin-apg-115-alone-or-in-combination-with-lisaftoclax-apg-2575-for-the-treatment-of-pedi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-differences-in-immune-related-adverse-events-requiring-hospitalization-among-patients-with-check 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-characteristics-and-treatment-outcomes-of-adenoid-cystic-carcinoma-acc-by-differ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/de-escalation-of-neoadjuvant-chemotherapy-for-her2-positive-breast-cancer-a-systematic-review-and-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-progression-in-mgus-using-transformer-based-survival-time-series-modeling 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cyclin-amplification-in-biliary-tract-cancer-integrated-profiling-to-evaluate-immune-exclusion-dru 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-to-response-with-hmavenetoclax-as-a-predictor-of-survival-in-acute-myeloid-leukemia-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-the-relationship-between-social-support-and-inflammatory-markers-among-patients-with-gynec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-institutional-single-arm-phase-2-study-of-durvalumab-plus-amrubicin-in-patients-with-relap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-an-artificial-intelligence-based-deep-learning-imaging-model-for-early 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-patient-navigation-to-identify-individual-needs-and-offer-medical-and-supportive-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-retrospective-hecog-phase-iii-trial-validation-of-polaris-tme-for-the-prediction-of-tils 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rationale-315-post-hoc-analysis-of-event-free-survival-by-surgically-relevant-subgroups-treated-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-nutritional-risk-in-chimeric-antigen-receptor-t-cell-car-t-therapy-protein-ener 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-implications-of-context-dependent-oncogenic-ipik3cai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiotherapy-followed-by-systemic-therapy-and-tislelizumab-in-microsatellite-stable-rectal-cancer-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/harnessing-omop-cdm-for-multisite-collaborations-to-measure-cardiovascular-risk-factors-and-cardiova 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-iidhi-co-mutations-with-treatment-ou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-a-bispecific-anti-pd-1ctla-4-antibody-for-patients-with-dmmrmsi-h-metastatic-colorec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-advanced-practice-provider-led-new-consults-in-community-oncology-expanding-access-and-vo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subsequent-therapies-and-time-to-second-progression-free-survival-events-pfs2-in-treatment-naive-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicentre-trial-of-telemonitored-circadian-rhythms-and-electronic-patient-reported-outcomes-epros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/household-costs-of-breast-cancer-and-coping-mechanisms-in-kenya-a-case-of-kenyatta-national-hospita 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aqp4-and-mog-as-definers-of-distinct-autoantibody-signatures-in-immune-checkpoint-inhibitor-induced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/measuring-keynote-522-response-from-tnbc-patient-biopsies-ex-vivo-using-the-e-slice-assay 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-access-to-effective-post-progression-therapies-on-survival-outcomes-in-first-line-randomiz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/income-inequality-and-cervical-cancer-a-comparative-analysis-of-demographics-and-healthcare-burden 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shr-a1811-plus-chemotherapy-and-bp102-as-1l-therapy-for-her2-expressing-mcrc-data-from-a-phase-ibi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-global-burden-of-thyroid-cancer-from-1990-to-2023-with-forecasts-to-2050 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-randomized-trial-to-evaluate-the-impact-of-anselamimab-on-all-cause-mortality-in-k-light-cha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-tirzepatide-versus-metformin-and-insulin-in-type-2-diabetes-patients-across 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-receptor-agonist-therapy-and-cancer-risk-and-mortality-in-patients-with-moderate-ckd-a-nation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-based-clinical-genetic-cg-prognostic-model-for-radiographic-progression-free 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-antibody-drug-conjugate-adc-eligibility-and-corresponding-prognosis-in-her2-early-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-cell-profiling-by-spectral-cytometry-to-predict-response-to-avelumab-in-advanced-bladder-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bi-1808-pembrolizumab-responses-to-a-chemotherapy-free-regimen-in-advanced-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-plasma-ctdna-genomic-biomarkers-identified-by-whole-exome-sequencing-and-a-novel-bioinfo-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ib-evaluation-of-a-recombinant-overlapping-peptide-survivin-immunotherapy-safety-immunogenic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-fruquintinib-combined-with-sintilimab-and-chidamide-in-refractory-mss-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-liquid-biopsy-training-on-real-world-testing-practices-for-advanced-nsclc-across-latin-ame 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obx-115-engineered-tumor-infiltrating-lymphocyte-til-cell-therapy-with-regulatable-membrane-bound 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-with-lifleucel-tumor-selection-and-dead-in-therapy-from-a-single-institution 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genomic-characterization-of-de-novo-prostate-cancer-presenting-with-psa-100-ngml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durvalumab-plus-platinum-etoposide-in-extensive-stage-extrapulmonary-small-cell-carcinoma-es-epscc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/continual-depletion-of-circulating-tumor-cells-using-an-automated-device-enriched-with-affinity-glas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-study-of-op-3136-a-novel-oral-selective-kat6ab-inhibitor-as-monotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-of-iegfri-and-ikras 2026-08-24 monthly 0.7 https://rjrindex.com/articles/staged-dose-escalation-of-adjuvant-abemaciclib-in-high-risk-hrher2-early-breast-cancer-first-saf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-neoadjuvant-immunochemotherapy-followed-by-surgery-in-locally-advanced-buccal-squamous-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/who-gets-access-national-discrepancies-in-clinical-trial-enrollment-among-patients-with-brain-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-implementation-of-electronic-patient-reported-outcomes-epros-for-remote-symptom-monitorin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/microbiome-associations-with-chemotherapy-induced-nausea-and-vomiting-a-metagenomic-shotgun-sequenc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-overall-survival-outcomes-of-belzutifan-treatment-in-advanced-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-baseline-quality-of-life-qol-and-early-death-in-patients-with-metastatic-renal-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-clinical-activity-and-preclinical-basis-of-panitumumab-based-egfr-blockade-in-smarcb1-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/central-nervous-system-metastases-in-hereditary-breast-cancer-according-to-germline-pathogenic-varia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-after-stereotactic-radiosurgery-versus-whole-brain-radiotherapy-for-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-circulating-tumor-dna-surveillance-as-predictor-of-progression-in-advanced-non-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-pathologic-response-using-a-taxane-based-gene-expression-signature-in-rna-sequencing-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup18sup-f-f-nym124-for-safety-imaging-and-dosimet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-modeling-for-predicting-60-day-prognosis-in-newly-diagnosed-advanced-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-genomic-and-microenvironmental-profiles-of-brain-metastases-in-renal-cell-carcinoma-insigh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-ai-decision-support-in-a-rapidly-evolving-therapeutic-landscape-ie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-related-efficacy-of-antibody-drug-conjugates-in-solid-tumors-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-cancer-stem-cells-with-a-novel-virus-like-drug-conjugate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shr-1701-combined-with-fuzuloparib-and-chemotherapy-as-first-line-therapy-for-advanced-lung-squamous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-analysis-and-deep-learning-integration-to-enhance-tumour-classification-in-total-body-petct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-trial-of-til-therapy-for-metastatic-uveal-melanoma-evaluation-of-t-cell-potency-and-an-in-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-clinical-profile-of-immune-related-adverse-events-iraes-associated-with-immune 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-phase-iii-study-for-newly-diagnosed-maximally-resected-glioblastoma-compar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-frailty-measures-on-overall-survival-in-prostate-cancer-a-systematic-review-and-meta-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-social-isolation-with-overall-survival-in-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-neoadjuvant-chemotherapy-nac-in-older-patients-with-locally-advanced-colon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-analysis-of-a-heavily-pretreated-population-of-patients-with-bone-sarcomas-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conditional-survival-by-primary-extranodal-site-in-diffuse-large-b-cell-lymphoma-a-population-based 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-vegf-a-concentrations-as-a-predictive-biomarker-of-immunotherapy-response-in-refractory-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-androgen-deprivation-therapy-adt-plus-androgen-receptor-pathway-inhibitors-arpis-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-and-management-of-gastrointestinal-gi-adverse-events-aes-with-zanidatamab-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/closing-the-depression-gap-in-community-oncology-real-world-outcomes-from-collaborative-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-volunteer-integrated-palliative-home-visits-on-psychological-well-being-among-metastatic-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-and-concordance-of-a-large-language-model-chatgpt-5-as-a-clinical-decision-support-too 2026-08-24 monthly 0.7 https://rjrindex.com/articles/culmerciclib-cdk246-inhibitor-plus-fulvestrant-in-hrher2-advanced-breast-cancer-after-progres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endocrine-therapy-non-adherence-and-recurrence-risk-in-patients-with-breast-cancer-and-major-depress 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-ml-to-predict-rapid-progression-for-patients-pts-with-hrher2-metastatic-breast-cancer-mb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/organ-specific-proteomic-aging-clocks-pacs-and-mortality-in-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-of-combination-gemcitabine-gem-and-nab-sirolimus-nab-s-in-advanced-leiomyosarcomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/heart-failure-in-hospitalizations-for-hematologic-malignancies-versus-solid-tumors-national-burden 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-shared-neoantigen-peptide-library-to-promote-personalized-vaccine-strategy-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pan-cancer-prevalence-molecular-landscape-and-prognostic-impact-of-iccne1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-individuals-with-cancer-and-pre-existing-autoimmune-disease-receiving-immune-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-mortality-and-length-of-stay-associated-with-splanchnic-vein-thrombosis-in-gastrointestina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intrathecal-ipsc-derived-natural-killer-cells-combined-with-the-stupp-regimen-for-newly-diagnosed-wh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cadonilimab-in-patients-with-msi-hdmmr-locally-advanced-or-metastatic-gastro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/minimally-invasive-vs-open-pancreaticoduodenectomy-for-periampullary-tumors-a-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-safety-and-cytokine-profiling-with-addition-of-the-toll-like-receptor-tlr-78-dual-agon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-primary-malignancies-after-car-t-versus-sct-in-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-fes-pet-imaging-in-the-management-of-estrogen-receptor-positive-breast-cancer-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discovery-of-novel-biomarkers-for-glioblastoma-using-vhh-antibodies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fusion-positive-early-stage-and-locally-advanced-lung-cancers-a-real-world-analysis-of-event-free 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-or-concurrent-immunotherapy-with-locoregional-radiotherapy-in-de-novo-metastatic-nasophar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-fruquintinib-in-refractory-metastatic-colorectal-cancer-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-rural-urban-disparities-in-radiotherapy-utilization-for-oral-cavity-and-pharyngeal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-predictors-and-disparities-in-second-primary-malignancy-risk-and-survival-after-index-head 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delayed-time-to-treatment-initiation-among-patients-with-hpv-associated-oropharyngeal-squamous-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cd56-and-p16-expression-in-the-differential-diagnosis-of-papillary-thyroid-carcinoma-and-benign-foll 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-us-based-retrospective-observational-study-of-biomarker-testing-patterns-across-lines-of-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mechanism-driven-comparative-safety-signals-of-capivasertib-versus-cdk46-inhibitors-a-faers-pharma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-iii-study-of-en002-gel-a-first-in-class-drip-inhibitor-in-non-melanoma-skin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anatomical-and-clinical-heterogeneity-of-dmmr-colorectal-cancer-by-tumor-location 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-akt-inhibitor-ntq1062-combined-with-fulvestrant-in-patients-with-hr-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multilevel-disparities-in-hiv-associated-gastrointestinal-cancer-mortality-in-the-united-states-199 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-exposome-driven-cancer-incidence-patterns-using-multi-cancer-principal-components-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-the-investment-in-metastatic-breast-cancer-research-sufficient-and-aligned-with-patient-prioritie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-atezolizumab-versus-durvalumab-in-extensive-stage-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-of-central-nervous-system-metastases-occurrence-in-patients-with-metastatic-breast-cancer-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cachexia-index-allostatic-load-and-body-composition-phenotypes-in-racially-and-ethnically-diverse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-biennial-mammography-on-stage-at-diagnosis-and-outcomes-of-breast-cancer-in-the-brazilian 2026-08-24 monthly 0.7 https://rjrindex.com/articles/features-of-gene-copy-number-variation-regulating-mitochondrial-function-in-endometrial-cancer-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pooled-analyses-of-clinical-outcomes-with-afamitresgene-autoleucel-afami-cel-in-metastatic-synovia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-sglt2-inhibitor-dapagliflozin-on-anticancer-resistance-and-alpelisib-and-fulvestrant-ind 2026-08-24 monthly 0.7 https://rjrindex.com/articles/upfront-low-dose-diet-modified-nilotinib-versus-standard-imatinib-in-indian-patients-with-newly-diag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hpv-stratified-tissue-factor-expression-and-multi-omic-correlates-of-overall-survival-after-tisotuma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-treatment-patterns-of-patients-with-metastatic-urothelial-cancer-in-france-results-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ibii-trial-of-first-line-trastuzumab-nivolumab-gemcitabine-and-cisplatin-in-her2-positiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/access-to-trastuzumab-deruxtecan-for-her2-low-metastatic-breast-cancer-in-brazils-unified-public-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-and-the-genomic-landscape-of-aml-in-precision-oncology-an-analysis-using-ash-hematomics-program 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tp53-mutation-adoption-of-stromal-adhesionneuronal-like-programs-as-a-driver-of-stress-adaptation-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-oncologic-outcomes-of-psma-pet-guided-salvage-radiotherapy-for-biochemical-recurrence-afte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expert-validation-of-an-artificial-intelligence-enabled-trial-matching-solution-using-real-world-dat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/greening-a-chemotherapy-day-ward 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-dll3-expression-and-tumor-subtype-on-response-to-tarlatamab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-microsatellite-instability-high-msi-hmismatch-repair-deficient-dmmr-bili 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-association-of-adjuvant-endocrine-therapy-et-after-pathologic-complete-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-sociodemographic-disparities-in-place-of-death-among-adults-with-pancreatic-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-adherence-to-interstitial-lung-disease-ildpneumonitis-toxicity-management-guidelines-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ai-based-risk-stratification-integrating-routine-laboratory-data-with-age-on-screening-vol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-tamoxifen-for-pre-cancer-and-early-disease-a-pooled-analysis-by-menopausal-status 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-radical-radiotherapy-in-de-novo-low-burden-metastatic-hormone-sensitive-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-factors-associated-with-glucagon-like-peptide-1-receptor-agonists-prescription-for-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-and-validation-of-a-methylation-signature-as-a-prognostic-marker-in-osteosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-multivariable-prognostic-model-for-pathological-response-using-anatomical-and-patho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-tagraxofusp-hyper-cvad-and-venetoclax-for-patients-with-newly-diagnosed-or-rel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/protact-preliminary-data-from-a-first-in-human-phase-1-study-evaluating-the-safety-tolerability 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-genetic-testing-patterns-in-prostate-cancer-assessed-via-artificial-intelligence-implica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-presentation-of-brain-metastases-by-breast-cancer-subtype-and-potential-implications-for-surveil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-ethnically-and-racially-diverse-patients-with-gynecologic-malignancies-in-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-financial-toxicity-from-cancer-care-travel-in-a-geographically-isolated-us-health-syst 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overcoming-immunotherapy-resistance-in-advanced-melanoma-through-radiotherapy-a-prospective-observa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-treatment-patterns-and-outcomes-of-common-solid-tumors-in-arab-american-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-modalities-among-long-term-survivors-of-primary-pulmonary-nut-carcinoma-a-systematic-revi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-time-and-financial-toxicity-of-travel-for-intravesical-chemotherapy-rationale-for-in-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-ad-and-neoadjuvant-nad-strategies-in-higher-risk-hormone-receptor-positive-hrher2-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-palmar-plantar-erythrodysesthesia-syndrome-ppes-hypothyroidism-and-clinical-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibition-for-advanced-cutaneous-squamous-cell-carcinoma-in-patients-with-concomi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-benefit-of-oral-selective-estrogen-receptor-degraders-in-iesr1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/momentum-a-phase-2-open-label-single-arm-multicenter-study-to-evaluate-the-efficacy-of-cemsidomi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ascend-a-phase-12-dose-escalation-optimization-and-dose-expansion-study-to-evaluate-the-safety 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-oncology-research-mapping-in-morocco-patterns-quality-and-unmet-needs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-ctdna-detection-in-prostate-cancer-using-a-6-base-epigenomics-and-fragmentomics-approa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-complete-response-and-association-with-survival-benefit-in-hormone-receptor-positive-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-malignant-melanotic-nerve-sheath-tumors-mmnst-a-retrospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-procedure-related-mortality-among-older-us-adults-with-digestive-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/restoring-form-rethinking-function-the-dual-edged-impact-of-maxillofacial-prostheses-on-survival-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-perioperative-esketamine-on-postoperative-recovery-in-breast-cancer-patients-undergoing-mo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-outcomes-in-acute-myeloid-leukemia-a-contemporary-national-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolving-trends-in-young-adult-ya-gastrointestinal-gi-cancer-philadelphia-in-national-context 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lymph-node-ratio-and-patterns-of-recurrence-in-oral-squamous-cell-carcinoma-treated-with-surgery-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologists-knowledge-clinical-practices-barriers-and-facilitators-of-cardio-oncology-guideline-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-study-of-a-novel-portable-scalp-cooling-cap-for-prevention-of-chemotherapy-induced-alope 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-specific-cancer-types-and-polyarteritis-nodosa-among-hospitalized-patients-in-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progress-implementation-of-a-novel-hybrid-decentralized-clinical-trial-to-support-precision-oncolog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-first-line-osimertinib-plus-chemotherapy-versus-amivantamab-plus-lazertinib-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shifting-patterns-in-pmbcl-and-dlbcl-care-the-role-of-community-oncology-centers-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-characteristics-of-a-phase-iii-randomized-controlled-trial-of-acupuncture-for-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/compassionate-release-for-incarcerated-patients-with-cancer-a-nationwide-policy-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-palliative-radiation-and-association-with-end-of-life-quality-metrics-and-healthcare-utilizat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-patients-with-head-and-neck-cancer-in-argentina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-risk-of-second-primary-malignancies-in-esophageal-cancer-survivors-insights-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-early-tacrolimus-levels-on-survival-outcomes-following-allogeneic-hematopoietic-stem-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genetic-characteristics-of-msi-high-versus-mss-gastric-cancer-patients-a-single-instit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peri-operative-nab-paclitaxel-with-sequential-radiotherapy-in-cardiac-angiosarcoma-a-single-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/basic-palliative-care-assessments-in-the-treatment-of-urological-oncology-patients-a-prospective-cr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-based-on-voice-based-artificial-intelligence-vaaipro-a-fast-and-innovat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-breast-cancer-stage-at-diagnosis-over-two-decades-in-cote-divoire 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integration-of-individual-sev-with-single-cell-analysis-to-reveal-association-of-immune-cell-subsets 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-unstructured-oncology-ehrs-to-regulatory-grade-real-world-evidence-a-next-generation-registry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-pretreatment-neutrophil-to-lymphocyte-ratio-in-triple-negative-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-utility-of-baseline-hypoalbuminemia-vs-peripheral-immune-biomarkers-in-a-real-world-immu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-cancer-screening-in-nigeria-findings-from-a-multi-city-community-based-psa-testing-outreac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-transarterial-therapy-combined-with-donafenib-plus-pd-1-inhibitors-for-unrese 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-outcomes-screening-rates-and-health-behaviors-by-county-level-poverty-status 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nutraceutical-therapies-for-radiation-induced-injury-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeted-sensorimotor-training-vs-general-aerobic-exercise-for-chemotherapy-induced-peripheral-neur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expression-levels-of-clock-genes-iper2i-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/construction-of-a-whole-course-psychological-nursing-model-and-its-impact-on-compliance-with-innovat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-detection-of-brca-associated-cancer-risk-and-lynch-syndrome-in-genomic-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-exploratory-study-of-the-potential-clinical-impact-of-ethnicity-in-patients-with-retroperitoneal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-neoadjuvant-concurrent-chemoradiotherapy-with-epirubicin-ifosfamide-in-locali 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyzing-dual-threat-shifts-in-gastric-carcinoma-and-sepsis-mortality-in-the-united-states-from-199 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ish2b3i-in-myeloid-neoplasms-potential-pathogenic-role-of-variants-of-unce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/employment-status-and-occupational-patterns-among-working-age-us-cancer-survivors-2020-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/actfirst-a-phase-3-trial-of-sup225sup-ac-psma-617-plus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nrg-hn006-randomized-phase-iiiii-trial-of-sentinel-lymph-node-biopsy-versus-elective-neck-dissecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-1-dose-escalation-and-expansion-study-of-pin-5018-a-ck1a-selective-molecular-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-with-management-of-crs-and-icans-following-cd3xcd20-bispecific-antibody-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-glp-1-receptor-agonists-on-outcomes-in-hepatocellular-carcinoma-patients-treated-with-atez 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-olutasidenib-in-combination-with-azacitidine-followed-by-olutasidenib-maintenance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-arm-study-of-irinotecan-liposome-ii-combined-with-adebrelimab-gemcitabine-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-between-early-on-treatment-weight-change-and-overall-survival-across-targeted-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-characteristics-treatment-patterns-and-contrast-enhanced-computed-tomography-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographics-and-trends-of-acute-myeloid-leukemia-among-young-adults-in-the-united-states-and-puerto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-evaluation-of-an-ai-based-fusion-prioritization-agent-for-oncogenicity-assessment-in-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-mood-and-anxiety-disorders-in-cancer-survivors-a-systematic-review-and-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-cancer-oriented-geriatric-assessment-coga-clinic-to-promote-age-friendly-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characterization-of-abl-kinase-domain-mutations-associated-with-imatinib-resistance-in-chr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-survival-outcomes-of-a-large-cohort-of-patients-diagnosed-with-diffuse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-automated-quantitative-evaluation-of-lesion-response-heterogeneity-in-patients-with-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expression-of-cxcr4-in-gastric-nens 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rivaroxaban-versus-low-molecular-weight-heparin-in-cancer-associated-thrombosis-assessment-of-clini 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-outcomes-and-resource-utilization-by-complication-clustering-phenotypes-among-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-characteristics-and-prognostic-predictors-in-cervical-clear-cell-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-large-language-models-to-assess-adherence-to-asco-tele-health-in-oncology-standards-in-post-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-burden-of-breast-cancer-among-women-aged-70-years-global-trends-in-dalys-and-mortality-by-soci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-peptide-decoy-dmp39-targeting-mitochondrial-metabolism-to-enhance-chemotherapy-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-pharmacologic-aldh2-activation-on-alcohol-driven-tumor-progression-in-aldh2-deficient-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-dnarna-co-detection-and-dna-only-ngs-for-driver-gene-identification-and-co-mutation-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-evolution-following-treatment-with-sacituzumab-govitecan-for-metastatic-breast-cancer-a-prote 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-lecture-on-knowledge-of-im-residents-in-diagnosing-and-managing-crs-and-icans 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-cytokine-and-transcriptomic-profiling-of-immune-related-adverse-events-in-early-stage-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-ki-67-with-tumor-fraction-in-metastatic-hr-positive-invasive-lobular-and-no-special-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/merkel-cell-carcinoma-incidence-trends-and-survival-rates-among-adults-from-united-states-cancer-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-characterization-of-brain-metastasis-in-colorectal-cancer-to-reveal-patterns-of-clonal-evolu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-3-study-marslight-11-evaluating-ibi363-tak-928-versus-docetaxel-in-patients-pt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/osimertinib-combined-with-bevacizumab-and-chemotherapy-as-1l-treatment-in-egfr-mutated-metastatic-no 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-pathways-of-immune-checkpoint-inhibitor-induced-hepatitis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-central-neurocytoma-in-a-multi-institutional-cohort-the-role-of-radiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/infection-burden-with-bcma-versus-gprc5d-targeted-bispecific-antibodies-in-multiple-myeloma-a-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-bmi-and-bmi-and-charlson-comorbidity-index-on-mortality-in-pancreatic-cancer-a-single-ins 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-interactions-between-pharmaceutical-industry-and-oncologists-in-africa-a-secondary-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adaptive-radiotherapy-as-a-strategy-for-universal-dosimetric-accuracy-across-tumor-sizes-and-locatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-mrna-covid-19-vaccination-near-immune-checkpoint-inhibitor-initiation-with-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-basket-trial-of-precision-til-therapy-for-immunotherapy-resistant-advanced-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-imm2510-a-pd-l1-vegf-bispecific-antibody-in-participants-with-advanced-io-treate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-immunoscore-for-prognostic-stratification-in-hpv-associated-oropharyngeal-cancer-an-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathological-outcomes-of-neoadjuvant-osimertinib-based-therapies-versus-chemotherapy-in-resectable-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/canadian-cancer-trials-group-cctg-study-pr21-pludo-results-of-crossover-treatment-from-a-random 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-the-ability-of-decipher-prostate-genomic-classifier-dgc-gt085-to-identify-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-activity-and-safety-of-rnk08954-in-advanced-non-small-cell-lung-cancer-nsclc-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologic-outcomes-following-biologic-therapy-for-immune-related-cutaneous-adverse-events 2026-08-24 monthly 0.7 https://rjrindex.com/articles/swog-s2107-randomized-phase-ii-trial-of-encorafenib-and-cetuximab-with-or-without-nivolumab-for-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-vivo-cd19-car-t-cell-therapy-str-p004-to-induce-remission-in-patients-with-autoimmune-diseases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-free-survival-after-next-line-of-treatment-pfs2-and-subsequent-therapies-subs-tx-in-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cd4-t-cell-reconstitution-and-cd4cd8-inversion-following-lymphodepleting-chemotherapy-for-tumor-inf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tremelimumab-t-durvalumab-d-chemotherapy-ct-vs-pembrolizumab-p-ct-in-1l-non-squamous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-pyrotinib-vs-pertuzumab-therapy-for-her2-positive-early-breast-cancer-the-helen-her-013 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1a-study-results-for-ima203cd8-a-prame-directed-t-cell-receptor-tcr-t-cell-therapy-in-ovar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-from-zzfirst-a-randomized-phase-2-trial-of-enzalutamide-ez-and-talazoparib-tala-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-results-from-the-optima-phase-iii-randomized-non-inferiority-trial-of-test-directed-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-radiotherapy-versus-observation-following-curative-surgery-for-early-stage-oral-squamous-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-circulating-tumor-dna-ctdna-dynamics-in-patients-pts-with-microsatellite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-characteristics-management-and-outcomes-of-genomically-defined-mismatch-repair-def 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-nitrogen-metabolism-in-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-double-blind-two-arm-single-dose-parallel-study-to-compare-the-pharmacokinetics-ph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-1-study-of-tqb6411-an-egfrc-met-bispecific-antibody-drug-conjugate-adc-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-all-tumor-agnostic-biomarkers-equally-tissue-independent-comparative-cross-histology-efficacy-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-of-tumor-microenvironment-in-istk11i-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/engineering-and-preclinical-evaluation-of-cxcr3-expressing-egfr-targeted-car-nk-cells-for-tumor-hom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allogeneic-cd19-targeted-car-t-therapy-brl-301-for-relapsed-or-refractory-b-cell-acute-lymphoblast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pan-cancer-computational-analysis-of-adaptive-immune-and-vascular-changes-in-primary-versus-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-tumor-genomics-and-fes-pet-in-estrogen-receptor-positive-er-breast-cancer-bc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-level-os-prediction-in-nsclc-combining-real-world-data-and-published-trial-results 2026-08-24 monthly 0.7 https://rjrindex.com/articles/definitive-bladderpelvic-radiation-after-enfortumab-vedotin-pembrolizumab-for-advanced-urothelial-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-more-always-better-outcomes-of-tip-versus-platinum-doublet-neoadjuvant-chemotherapy-in-high-ris 2026-08-24 monthly 0.7 https://rjrindex.com/articles/small-cell-prostate-cancer-risks-for-metastatic-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-ifebemtinib-in10018-combined-with-garsorasib-d-1553-in-kras 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-immune-checkpoint-inhibitors-in-patients-aged-65-74-versus-75-years-with-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-remodeling-of-the-extracellular-vesicle-proteome-during-systemic-therapy-in-advanced-non-sma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunologic-and-clinical-outcomes-of-perfluoroalkyl-substances-pfas-exposure-in-solid-tumors-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-safety-of-tarlatamab-in-patients-receiving-recent-or-concurrent-cns-radiation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-national-analysis-of-in-hospital-outcomes-following-cytoreductive-surgery-with-hipec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-study-on-the-efficacy-of-cd4tgf-v-bispecific-antibody-mr001-and-temozolomide-combinat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-associated-with-egfr-and-her2-alterations-in-advanced-urothelial-carcinoma-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-trial-of-io102-io103-and-nivolumab-relatlimab-in-previously-untreated-unresectable-melano 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantitative-ct-lung-fibrosis-and-immune-checkpoint-inhibitor-related-pneumonitis-in-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-alk201-a-fgfr2b-targeting-antibody-drug-conjugate-adc-for-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-vivo-car-t-cell-engineering-in-b-cell-malignancies-a-systematic-review-of-emerging-clinical-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incremental-prognostic-value-of-an-ai-derived-histology-signature-beyond-the-21-gene-recurrence-scor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-haematological-control-long-term-renal-outcomes-of-imatinib-therapy-in-chronic-myeloid-leuka 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-market-entry-of-biosimilars-in-the-us-on-cancer-biologics-pricing-strategies-market-shar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/connectome-sparing-stereotactic-radiosurgery-results-from-the-phase-ii-cog-srs-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comeback-from-long-course-adt-with-relugolix-rel-and-darolutamide-daro-in-hormone-sensitive-pros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/forecasting-global-disparities-in-cervix-and-corpus-uteri-cancers-globocan-2022-2040-projections 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-priming-with-the-ezh2-inhibitor-tazemetostat-in-b-cell-lymphomas-receiving-car-t-cell-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-lisocabtagene-maraleucel-liso-cel-in-patients-pt-with-relapsed-or-refractory-rr-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patient-characteristics-outcomes-and-resource-utilization-of-chimeric-antigen-receptor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-characterization-of-hif-2a-and-carbonic-anhydrase-ix-expression-and-the-genomic-landsc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-promise-prp-success-rates-of-paired-biopsies-and-biomarker-testing-results-for-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-epigenomic-molecular-tumor-type-prediction-for-biliary-tract-cancer-in-cup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-phosphoproteomic-signatures-in-peripheral-blood-and-prediction-of-durable-response-to-car-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-between-clinical-utility-and-coverage-real-world-impact-of-unreimbursed-ngs-testin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-and-molecular-profiling-of-ipteni-loss 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intratumoral-heterogeneity-of-imtapi-loss-by-immunohist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-associations-between-patient-and-caregiver-quality-of-life-following-hematopoietic-stem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-focus-in-neoadjuvant-chemoimmunotherapy-an-analysis-of-pathologic-complete-response-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/standard-dose-ripretinib-plus-sunitinib-versus-ripretinib-dose-escalation-in-advanced-gist-after-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incretin-based-therapies-and-all-cause-mortality-and-progression-to-multiple-myeloma-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/organ-and-histology-specific-molecular-and-immune-landscape-of-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-different-metrics-for-estimating-kidney-radiation-exposure-during-treatment-for-childh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oral-selective-estrogen-receptor-degraders-in-hrher2-advanced-breast-cancer-and-impact-of-esr1-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-outcomes-for-elderly-patients-with-dlbcl-treated-at-academic-vs-community-programs-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-of-day-administration-of-immunotherapy-in-early-stage-triple-negative-breast-cancer-immune-dep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-concomitant-inpm1i-mutations-on-genomic-and-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/structural-determinants-compared-with-genetic-ancestry-and-self-reported-race-in-triple-negative-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meaning-distress-and-desire-for-hastened-death-in-homebound-adults-with-advanced-cancer-a-cluster 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-socioeconomic-disparities-in-the-elderly-population-with-mycosis-fungoides-and-sezary-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cumulative-toxicity-assessed-by-area-under-the-curve-auc-in-targeted-therapy-versus-chemotherapy-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-predicted-natural-killer-cell-fitness-to-guide-daratumumab-and-transplant-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/divergent-transcriptomic-signatures-and-microenvironmental-markers-of-ikrasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-tumor-gene-expression-analysis-of-sacituzumab-govitecan-sg-and-trastuzuma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-circulating-tumor-dna-profiling-for-prediction-of-long-term-clinical-benefit-in-pmmr-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-by-lobular-lob-histology-status-at-initial-diagnosis-in-patients-pts-in-the-inavo120-ph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-of-her2-altered-nsclc-in-china-a-retrospective-multi-cen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-bone-health-outcomes-following-tamoxifen-and-aromatase-inhibitor-therapy-in-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-1l-divarasib-plus-pembrolizumab-pembro-in-advanced-or-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/all-that-glitters-is-not-gold-the-importance-of-ruling-out-other-causes-of-leptomeningeal-enhanceme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-impact-of-venous-thromboembolism-and-metastatic-disease-on-in-hospital-mortality-and-30 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-chemotherapy-with-survival-in-node-positive-penile-squamous-cell-carcinoma-stratified 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fast-tracking-precision-oncology-for-rare-cancers-a-national-decentralized-trial-offering-comprehen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-and-adjuvant-pembrolizumab-pembro-plus-standard-of-care-soc-for-resectable-locally-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-multicenter-open-label-parallel-cohort-study-to-evaluate-the-efficacy-safety-and-pharm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-subcutaneous-isa-vrd-isasocut-and-intravenous-isa-vrd-imroz-in-transplan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeted-bronchial-washing-fluid-based-sequencing-for-detection-of-actionable-genomic-alterations-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biological-subtype-discordance-after-neoadjuvant-therapy-in-early-breast-cancer-findings-from-a-15 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-class-trop2-targeted-pet-imaging-with-sup68sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/support-of-academic-non-clinical-efforts-for-cancer-investigator-faculty-at-association-of-american 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insights-through-the-renal-lens-clinical-outcomes-of-newly-diagnosed-multiple-myeloma-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-impact-of-regional-lymph-node-depletion-on-response-to-immune-checkpoint-blockade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-characteristics-and-survival-outcomes-of-typical-and-atypical-pulmonary-carcinoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-incidence-mortality-and-projections-of-early-onset-upper-gastrointestinal-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/external-validation-of-a-deep-learning-ct-biomarker-to-predict-first-line-immune-checkpoint-inhibito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/off-target-hla-matches-for-prediction-of-response-in-personalised-cancer-vaccines-a-multi-trial-ret 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-trial-of-a-kras-g12vhla-a1101-restricted-tcr-engineered-t-cell-therapy-in-advanced-solid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recovery-with-residual-disparities-real-world-patterns-of-platinum-chemotherapy-use-after-the-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-nivolumab-in-patients-at-high-risk-of-immune-related-adverse-events-a-retrospective-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-mass-index-stratified-outcomes-with-first-line-immunotherapy-in-metastatic-rcc-a-real-world-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-entpd1cd39-mediated-myeloid-t-cell-crosstalk-and-its-role-in-immunotherapy-resp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-mass-index-and-mortality-in-immune-checkpoint-inhibitor-treated-cancers-a-real-world-propensit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-assisted-prediction-of-radiation-failure-patterns-and-survival-after-stereotactic-radiosurgery-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-developing-braincentral-nervous-system-cns-metastases-across-multiple 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-to-assess-the-safety-tolerability-pharmacokinetics-and-preliminary-antitumor-acti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlative-analysis-between-external-and-internal-lymphedema-in-head-and-neck-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chromosomal-instability-and-integrated-tumor-margin-immune-ecosystem-remodeling-as-drivers-of-progre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-and-safety-results-from-rad-io-a-multi-stage-trial-of-durvalumab-with-chemoradiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-prehabilitation-and-functional-performance-signals-in-older-adults-undergoing-hepatobiliary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-palliative-care-nurse-coordination-in-symptom-control-and-care-planning 2026-08-24 monthly 0.7 https://rjrindex.com/articles/isabela-a-phase-2-study-of-isatuximab-belantamab-mafodotin-pomalidomide-and-dexamethasone-in-rel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-early-resistance-genomic-state-ergs-as-an-identifier-of-primary-cdk46-inhibitor-failure-in-hr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/defining-a-long-term-benefit-phenotype-to-pd-1-inhibitors-in-recurrentmetastatic-head-and-neck-squa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-dara-vrd-vrd-and-dara-rd-in-transplant-ineligible-older-adults-with-newly 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hidden-advanced-physiology-in-non-metastatic-gastrointestinal-cancer-malnutritioncachexia-and-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/actionable-genomic-alterations-and-outcomes-in-lung-squamous-and-adenosquamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-from-imvigor011-a-phase-3-study-of-circulating-tumor-ctdna-guided-adjuv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-multicenter-randomized-controlled-open-label-study-efficacy-and-safety-of-m701-epcamcd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-advanced-pneumatic-compression-devices-and-usual-care-on-psychosocial-outcomes-in-head-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-olaparib-and-ceralasertib-in-patients-with-recurrent-osteosarcoma-lung-only-resec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimal-timing-of-endocrine-therapy-interruption-for-pregnancy-in-young-women-with-hormone-receptor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-a-statin-a-day-keep-prostate-cancer-pc-away-statin-use-and-disease-progression-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-global-health-to-predict-negative-health-outcomes-in-patients-with-advanced-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-treatment-of-ql1706-in-patients-with-resectable-microsatellite-instability-highmismatch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-statin-prescription-for-secondary-prevention-of-atherosclerotic-cardiovascular-diseas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-bruton-tyrosine-kinase-inhibitors-versus-venetoclax-in-chronic-lymphocytic-le 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fgfr-targeted-therapies-in-advanced-esophagogastric-cancer-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-and-randomized-clinical-trial-comparison-in-patients-with-m-iidh1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-for-comprehensive-genomic-profiling-in-myeloid-malignancies-changes-in-detectio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-hiv-hepatitis-b-and-hepatitis-c-eligibility-language-in-immune-checkpoint-inhibitor-onco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/some-features-of-the-energy-metabolism-of-primary-cell-cultures-of-sarcomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-early-onset-colorectal-cancer-in-the-united-states-a-population-based-analysis-2000-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-national-patient-centered-ai-framework-for-equitable-oncology-clinical-trial-access-early-outcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-of-trastuzumab-deruxtecan-in-combination-with-stereotactic-radiosurgery-for-brain-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-large-language-models-to-identify-advance-care-planning-in-oncology-patients-who-present-to-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-care-in-armenia-an-assessment-of-diagnostic-and-treatment-capacity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-of-amivantamab-associated-scalp-toxicity-a-multicenter-retrospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/divergent-paths-in-the-right-colon-a-24-year-analysis-of-appendiceal-cancer-versus-cecal-cancer-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/operationalizing-yoga-as-a-quantifiable-component-of-guideline-aligned-multimodal-exercise-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/symptoms-and-life-impact-of-polycythemia-vera-pv-results-from-a-qualitative-patient-interview-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-treatment-cervical-cancer-surveillance-cytology-and-recurrence-outcomes-in-a-large-integrated-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atrial-fibrillation-as-a-sentinel-cardiovascular-event-in-renal-cell-carcinoma-hospitalizations-nat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-disparities-in-cervical-cancer-incidence-mortality-and-disability-adjusted-life-y 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-multidisciplinary-rounds-on-time-to-treatment-for-veterans-with-lung-cancer-at-a-va-medica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-lu-psma-based-treatment-strategies-in-metastatic-hormone-sensitive-prostate-cancer-a-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tp53-co-mutations-and-survival-outcomes-in-patients-pts-with-nsclc-bearing-uncommon-egfr-alteratio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-arm-phase-2-study-of-neoadjuvant-mirvetuximab-soravtansine-and-carboplatin-for-fra-express 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tace-haic-combined-with-low-dose-donafenib-for-unresectable-hepatocellular-carcinoma-a-real-world-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-exploratory-trial-of-cadonilimab-ak104-plus-gemcitabine-cisplatin-gc-as-a-conversion 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-mrna-2808-in-participants-with-relapsed-or-refractory-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-double-blind-phase-3-trust-iv-study-of-adjuvant-taletrectinib-vs-placebo-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/swog-s2414-insight-a-randomized-phase-iii-trial-incorporating-pathologic-complete-response-in-par 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-multicenter-phase-ii-trial-of-radioimmunotherapy-versus-chemoimmunotherapy-followed-by-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-induction-oxaliplatin-based-chemotherapy-followed-by-maintenance-in-isolated-peritoneal-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benchmarking-next-generation-large-language-models-llms-evaluation-of-patient-oriented-prostate-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/venous-thromboembolism-in-gynecologic-malignancies-as-a-chronic-vascular-disease-a-systematic-revie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-metabolite-network-modeling-of-metabolic-nodes-and-oncogenic-signaling-in-gastrointestina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antidepressant-use-and-overall-survival-in-ici-treated-pan-cancer-patients-a-real-world-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/belzutifan-plus-lenvatinib-versus-cabozantinib-in-post-pd-l1-renal-cell-carcinoma-rcc-health-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circrna-signatures-associated-with-brca-mutation-status-in-ovarian-cancer-and-a-rassf8-derived-candi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liraglutide-may-be-associated-with-increased-skin-cancer-risk-a-propensity-score-matched-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-insurance-related-disparities-on-delay-in-treatment-initiation-among-colorectal-cancer-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-level-trends-in-breast-cancer-incidence-staging-and-mortality-in-armenia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-response-and-surgical-conversion-after-preoperative-docetaxel-cisplatin-and-oral-5-fu-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-inferior-vena-cava-filters-in-breast-cancer-patients-with-dvt-national-inpatient-sample 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-first-line-pembrolizumab-plus-chemotherapy-in-metastatic-triple-negative-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-clinical-study-of-stereotactic-radiotherapy-srt-combined-with-chemotherapy-and-tisleliz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-in-hospital-mortality-in-chemotherapy-associated-cardiomyopathy-a-national-inpatient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-thyroid-dysfunction-and-overall-survival-in-metastatic-colorectal-cancer-treated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-pancreatic-cancer-risk-assessment-using-seer-medicare-claims-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-and-burden-of-thyroid-cancer-mortality-in-south-asia-a-retrospective-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-anticancer-therapy-near-the-end-of-life-a-binational-multicenter-analysis-in-argentina-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-outcomes-and-unmet-needs-in-patients-with-acute-myeloid-leukemia-aml-who-are-ineligible 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncosphere-ai-an-agentic-ai-multidisciplinary-clinical-workflow-support-tool 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accessibility-of-mandated-coverage-insurer-and-care-team-perspectives-on-barriers-for-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-and-clinical-outcomes-of-newly-diagnosed-acute-myeloid-leukemia-with-mapk-pathway-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-the-understanding-patient-assessment-of-goals-and-treatment-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-outcomes-with-olutasidenib-after-venetoclax-in-idh1-mutated-aml-using-real-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-inpatient-outcomes-with-carcinoid-syndrome-among-malignant-neuroendocrine-tumor-hospi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-telisotuzumab-adizutecan-abbv-400-temab-a-in-patients-with-advanced-solid-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pain-on-functional-status-quality-of-life-and-cognition-in-older-adults-with-prostate-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fitness-classification-and-induction-intensity-selection-in-aml-practice-a-contemporary-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequency-of-mutations-in-homologous-recombination-genes-in-patients-with-different-histological-typ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/facility-level-differences-and-outcomes-in-elderly-primary-cns-lymphoma-in-the-ncdb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-sepsis-related-mortality-among-adults-with-cancer-aged-25-years-in-united-states-1999-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-oxidative-stress-and-neutrophil-reprogramming-in-mediating-venous-thrombosis-in-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-based-breast-cancer-incidence-by-age-sex-subtype-and-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-second-primary-malignancies-spm-in-patients-with-chronic-lymphocytic-leukemiasma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigator-initiated-phase-ii-trial-of-absk043-an-oral-pd-l1-inhibitor-in-patients-with-angiogen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-versus-petct-at-end-of-treatment-in-large-b-cell-lymphoma-a-diagnostic-accuracy-meta-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-pyrotinib-plus-trastuzumab-combined-with-chemotherapy-for-her2hr-early-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-btn3a3-a-potential-biomarker-and-therapeutic-target-to-promote-glycolytic-metabolism-repro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proton-beam-therapy-versus-interventional-procedures-for-hepatocellular-carcinoma-a-systematic-revi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-testing-uptake-through-an-enhanced-oncology-nurse-led-intervention-in-patients-with-solid-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-car-t-cell-therapy-in-hematologic-malignancies-a-systematic-review-and-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-geographic-distance-from-transplant-center-on-the-risk-of-severe-graft-versus-host-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modeling-early-gastric-cancer-evolution-following-iarid1ai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-cerebrovascular-disease-related-mortality-in-patients-with-chronic-lymphoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-institutional-randomized-phase-iii-trial-comparing-anatomical-segmentectomy-and-lobectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-neoadjuvant-immunochemotherapy-chemoradiotherapy-and-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-analysis-of-the-investigator-initiated-randomized-study-of-anti-pd-l1-durvalumab-durva-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-world-oral-solution-formulation-of-enzalutamide-bioequivalence-versus-soft-gel-capsule-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-patient-tailored-protein-marker-blood-test-for-monitoring-treatment-response-and-postoperative-rec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-enzalutamide-and-darolutamide-for-non-metastatic-castration-resistant-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-bipolar-androgen-therapy-combined-with-sipuleucel-t-for-patients-with-metastatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adapt-m-a-tool-to-predict-individualized-benefit-from-adjuvant-anti-pd-1-pd-1-in-resected-high-ri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-germline-pathogenic-variants-in-melanoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-nanobody-sting-agonists-on-the-tumor-microenvironment-and-adoptive-cell-therapy-for-solid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-cross-resistance-of-sequential-antibody-drug-conjugate-therapy-in-her2-low-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-trial-of-atr-inhibitor-berzosertib-plus-immune-checkpoint-inhibitor-avelumab-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sensitivity-of-portal-vein-ctdna-versus-peripheral-blood-in-predicting-postoperative-liver-metastasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-biological-complexity-to-clinical-precision-a-first-in-class-single-patient-level-ai-strategy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/complementary-liquid-and-tissue-ngs-testing-to-identify-actionable-therapeutic-targets-missed-by-sin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-rationally-designed-local-delivery-platform-oncoplex-for-sustained-docetaxel-release-to-overcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-hypertension-mortality-among-patients-with-lung-cancer-a-retrospective-cd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-rare-cancers-treated-with-combination-immune-checkpoint-inhibitors-with-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-pelareorep-on-mutant-kras-specific-blood-til-clonal-expansion 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-durvalumab-treatment-duration-on-survival-and-healthcare-utilization-after-chemoradiation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiomics-feature-robustness-of-photon-counting-ct-and-dect-in-chest-tumor-phantom-a-dual-center-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-in-cancer-patients-treated-with-anchored-interleukin-12-il-12-immunotherapy-resul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-ai-in-hematology-and-oncology-fellowship-hof-training-a-multicenter-sur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/study-of-the-cytostatic-effect-of-a-new-compound-of-the-tropolon-series-on-primary-cultures-of-gliom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-de-novo-del17p-in-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-preliminary-efficacy-of-a-novel-armored-mesothelin-targeted-car-t-therapy-in-advanced-sol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-atezolizumab-durvalumab-lurbinectedin-and-tarlatamab-in-high-grade-extrapulmonary-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/individualized-recurrence-risk-prediction-as-a-challenge-to-conventional-eligibility-criteria-in-pha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-alterations-in-metastatic-renal-cell-carcinoma-mrcc-impact-on-survival-and-response-to-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-systems-level-omics-and-hallmark-based-analysis-of-pancreatic-cancer-for-the-identification-of-pot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stage-specific-survival-trends-in-small-cell-lung-cancer-in-the-united-states-a-population-based-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-objective-sarcopenia-assessment-into-geriatric-screening-as-a-predictor-of-treatment-tol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-fih-phase-iii-open-label-dose-escalation-and-expansion-study-of-ilkn421h-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-benmelstobart-combined-with-anlotinib-and-chemotherapy-as-neoadjuvant-therapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-decision-making-after-car-t-and-bispecific-antibody-therapy-in-relapsedrefractory-multipl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-and-mechanism-of-tertiary-lymphoid-structure-and-its-associated-b-cells-in-the-resistance-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-enfortumab-vedotin-plus-pembrolizumab-compared-with-platinum-based-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-cd-19-directed-car-t-therapy-in-patients-with-primary-and-secondary-central-nervous-syst 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-immune-profiling-of-ibrafi-mutated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ibi363-tak-928-plus-chemotherapy-as-first-line-1l-treatment-for-advanced-non-small-cell-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-socioeconomic-disparities-in-stage-at-diagnosis-and-survival-in-pancreatic-cancer-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-and-burden-of-multiple-myeloma-mortality-in-south-asia-a-retrospective-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/afatinib-versus-osimertinib-for-non-small-cell-lung-cancer-with-uncommon-epidermal-growth-factor-rec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-outcomes-by-patterns-of-progression-in-patients-with-advanced-renal-cell-carcinoma-from-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-a-10-item-frailty-index-based-on-a-comprehensive-geriatric-assessment-fi-cga-10-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-lobectomy-and-neoadjuvant-therapy-the-missing-link-in-improving-early-stage-small-cell-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-and-burden-of-pancreatic-cancer-in-the-united-states-a-retrospective-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accumulation-of-cholesterol-cortisol-and-glutathione-in-mitochondria-as-a-marker-of-metabolic-adap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-hematopoietic-recovery-of-high-dose-melphalan-with-stem-cell-rescue-as-bridging-to-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/urinary-tumor-dna-guided-de-escalation-of-systemic-immunotherapy-in-extensive-very-high-risk-non-mus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recent-trends-in-utilization-of-outpatient-medical-oncology-services 2026-08-24 monthly 0.7 https://rjrindex.com/articles/career-fulfillment-and-intent-to-leave-among-oncology-physicians-a-global-survey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expression-patterns-of-circulating-micrornas-in-classification-models-new-opportunities-in-brain-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-hlx43-anti-pd-l1-adc-in-patients-with-advanced-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-mortality-from-malignant-neoplasms-of-male-genital-organs-in-the-united-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthtree-survey-as-an-identifier-of-venous-thromboembolism-risk-mitigation-targets-in-newly-diagno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epimedin-a-to-prevent-glioblastoma-growth-and-invasion 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-intraoperative-diagnosis-and-grading-system-integrating-macroscopic-images-ct-imaging-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/xnw27011-a-claudin-182cldn182-targeted-antibody-drug-conjugate-adc-in-patients-with-cldn182 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ct-derived-visceral-fat-phenotypes-to-reveal-a-metabolically-defined-tofi-subgroup-in-a-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-ct-changes-pet-response-and-histopathologic-tumor-regression-in-treated-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-mortality-and-health-care-utilization-in-frail-older-patients-with-cancer-receiving-targ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhanced-financial-assistance-intervention-for-unmet-essential-needs-a-prospective-pilot-study-to-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-open-label-safety-tolerability-and-efficacy-study-of-hc-7366-in-combination-with-belz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-paradox-in-gastrointestinal-cancer-patients-on-immunotherapy-a-retrospective-multi-institut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transportation-insecurity-and-rbc-transfusion-burden-in-multiple-myeloma-and-related-plasma-cell-dis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ignite-cerala-a-phase-ii-signal-seeking-trial-of-ceralasertib-targeting-recurrent-high-grade-serous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-analysis-of-a-computational-reasoning-system-on-large-scale-tumor-genomic-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insights-from-initial-scoring-in-the-health-equity-report-card-herc-pilot-in-community-oncology-se 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-machine-learning-enhanced-analysis-of-temporal-trends-in-biomarker-based-eligibility-restrictions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-stage-ai-enabled-therapeutic-assets-an-industry-wide-analysis-of-scale-clinical-progressi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-and-gender-disparities-in-lung-cancer-mortality-in-guatemala 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-impact-of-first-immunotherapy-infusion-timing-on-outcomes-in-locally-advanced-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-implementation-of-an-integrated-exercise-medicine-model-within-routine-oncology-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-person-versus-telehealth-outpatient-palliative-care-visits-in-oncology-a-multicenter-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/natural-language-processing-assisted-chart-review-to-assess-documented-cannabis-use-in-electronic-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-lymph-node-dissection-extent-on-disease-free-survival-with-postoperative-nivolumab-plus-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/responses-to-trastuzumab-deruxtecan-t-dxd-in-her2-ihc-spectrum-2-versus-3-urothelial-carcinoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-psychosocial-status-of-children-who-have-a-parent-with-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/older-age-as-a-predictor-of-post-transplant-survival-in-newly-diagnosed-acute-myeloid-leukemia-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-omic-analysis-of-eocrc-divergent-methylation-and-gene-expression-signatures-in-young-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/value-of-risk-directed-thromboprophylaxis-in-ambulatory-lung-and-gastrointestinal-cancer-care-econo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/firmonertinib-combined-with-cisplatincarboplatin-plus-pemetrexed-as-neoadjuvant-therapy-in-resectab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/explainable-machine-learning-for-continuous-transcriptomic-modeling-of-metastatic-risk-in-prostate-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-cadonilimab-plus-chemotherapy-for-locally-advanced-gastricgastroesophageal-junction-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-testing-in-asian-american-and-pacific-islander-women-with-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-toxicity-of-first-line-systemic-therapy-for-hepatocellular-carcinoma-in-clinical-practice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reduced-treatment-adherence-and-cancer-mortality-in-patients-with-depression 2026-08-24 monthly 0.7 https://rjrindex.com/articles/major-adverse-cardiovascular-events-in-androgen-receptor-signaling-inhibitor-treated-patients-with-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-overall-survival-os-and-long-term-transfusion-independence-ti-from-the-phase-3-commands 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-cadherin-17-ca17-in-blood-as-a-diagnostic-biomarker-for-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-genomic-and-clinical-factors-with-outcomes-with-front-line-chemoimmunotherapy-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-optimized-multi-biomarker-panel-for-discriminating-lung-cancer-from-ldct-positive-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-overall-survival-outcomes-of-btk-inhibitors-vs-venetoclax-based-therapy-as-second-line-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcome-comparison-of-once-versus-twice-daily-dosing-of-zanubrutinib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-a-small-extracellular-vesicle-protein-based-ovarian-cancer-score-with-o-rads-ultrasound 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-results-of-perioperative-chemoimmunotherapy-with-dcf-and-avelumab-in-locally-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bone-mineral-density-changes-in-patients-treated-with-anti-pd-1-immune-checkpoint-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nalirifox-in-combination-with-adebrelimab-for-advanced-biliary-tract-cancer-a-phase-2-niofa-01-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-monitoring-for-early-detection-of-disease-recurrence-in-bonesoft-tissue-sarco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-safety-and-immunogenicity-of-pertuzumab-biosimilar-versus-reference-pertuzumab-in-combina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ia-study-of-vrn101099-a-brain-penetrant-highly-selective-covalent-her2-inhibitor-in-her2-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-brain-metastasis-outcomes-with-t-dxd-versus-tucatinib-based-therapy-in-second-line-her2-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transient-prostate-specific-antigen-flare-induced-by-lutetium-lu-177-vipivotide-tetraxetan-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-treatment-failure-despite-first-line-immunotherapy-in-real-world-msi-hdmmr-gastroesophageal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sepsis-severity-and-inpatient-outcomes-in-metastatic-cancer-a-national-inpatient-sample-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-1l-trastuzumab-deruxtecan-t-dxd-based-regimens-in-advanced-her2-expressing-gastric-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-and-predictive-impact-of-baseline-gene-expression-exp-in-the-natalee-trial-of-adjuvant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-national-database-derived-nomogram-for-predicting-postoperative-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-a-phase-2a-study-of-atebimetinib-in-combination-with-mgnp-in-advanced-or-metastatic-pan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/image-only-and-multimodal-ai-digital-pathology-biomarkers-to-demonstrate-risk-stratification-across 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodality-neoadjuvant-downstaging-therapy-before-liver-transplantation-for-colorectal-liver-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-rna-protein-profiling-of-antibody-drug-conjugate-adc-targets-in-leiomyosarcoma-lms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sys6010-combined-with-syh2051-in-advanced-solid-tumors-results-from-a-phase-ibii-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-a-cfdna-methylation-based-mced-test-in-patients-with-clinicoradiologic-suspicion-of-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-safety-and-efficacy-of-obinutuzumab-versus-rituximab-in-combination-with-chemotherapy-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-biomarkers-of-primary-resistance-to-anti-egfr-monoclonal-antibodies-mabs-by-comprehensive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/more-than-pain-relief-associations-between-provider-compassion-anxiety-and-burnout-in-ed-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addressing-geographic-disparities-in-cancer-care-an-examination-of-the-contributions-of-internation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-followed-by-transanal-endoscopic-surgery-tes-and-selective-chemoradiation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-safety-and-outcomes-of-ribociclib-versus-palbociclib-in-hormone-receptor-posi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-para-aortic-lymphadenectomy-on-prognosis-and-quality-of-life-in-preoperative-ib2-iia2-cerv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-synbindin-deficiency-on-immune-checkpoint-blocker-induced-systemic-inflammation-and-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-us-most-favored-nation-mfn-drug-pricing-on-global-oncology-access 2026-08-24 monthly 0.7 https://rjrindex.com/articles/activating-mpn-patients-through-empowering-patient-centered-education 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultra-refractory-pd-pd-pancreatic-cancer-clinical-and-molecular-insights-across-first-and-second-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durable-treatment-free-remission-in-cml-beyond-clinical-trials-lessons-from-a-large-single-center-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/revumenib-as-maintenance-for-aml-following-allogeneic-stem-cell-transplantation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-telephone-genetic-screening-program-in-breast-cancer-survivorship-in-the-bronx 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transplant-associated-thrombotic-microangiopathy-after-hematopoietic-stem-cell-transplantation-in-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-esophageal-cancer-mortality-in-the-united-states-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/challenges-in-identifying-her2-low-metastatic-breast-cancer-real-world-perspectives-from-a-nationwi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-features-and-survival-outcomes-of-her2-low-versus-her2-negative-ihc-0-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/line-of-therapy-and-proton-pump-inhibitor-use-as-prognostic-factors-in-advanced-soft-tissue-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preeclampsia-gene-signatures-and-pd-l1-in-endometrial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-quality-of-life-and-mood-in-prolonged-responders-to-immune-checkpoint-inhibitors-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/translating-meta-analytic-risk-into-absolute-survival-projection-modeling-of-secondary-type-mutatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-recurrence-patterns-and-postrecurrence-outcomes-after-neoadjuvant-chemoradiothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/drivers-of-clinician-engagement-in-oncology-trial-accrual-within-an-imc-in-shanghai-a-mixed-methods 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-use-in-subgroup-analysis-versus-enrichment-trial-design-as-a-predictor-of-oncology-trial-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sleep-disorders-in-cancer-survivors-a-cross-sectional-study-from-morocco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-stage-at-diagnosis-of-hiv-associated-cancers-a-seer-analysis-2018-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-mortality-in-patients-with-hiv-and-tumor-lysis-syndrome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-features-and-survival-outcomes-of-stage-ie-pulmonary-marginal-zone-lymphoma-a-nat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-in-place-of-death-amongst-black-women-with-breast-cancer-a-retrospective-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-pembrolizumab-in-combination-with-odetiglucan-for-patients-with-metastatic-colorec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/later-line-treatment-of-pd-1-and-ctla-4-blockade-combined-with-liposomal-irinotecan-plus-leucovorin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/day-7-single-cell-rna-sequencing-of-acute-lung-responses-after-17-gy-whole-thorax-irradiation-in-mic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rainfol-04-engot-ov96gog-3134-a-phase-3-open-label-randomized-study-of-rinatabart-sesutecan-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-of-hpb-092-a-dual-flt3irak4-inhibitor-in-relapsed-or-refractory-acute-myeloid-leu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fusionvac22-02-a-phase-i-clinical-trial-in-progress-adjuvant-idnajb1-prkaca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-parallel-cohort-multicenter-clinical-study-of-rezvilutamide-in-combination-with-andr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-differences-in-colorectal-cancer-screening-effectiveness-in-the-plco-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-between-circulating-tumor-dna-and-radiographic-disease-status-in-soft-tissue-sarcoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stratification-of-cardiovascular-complications-with-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sleep-disorder-diagnosis-prevalence-among-adult-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-survival-among-patients-with-early-onset-primary-liver-cancer-a-15 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-and-factors-associated-with-first-line-chemoimmunotherapy-chemoio-or-immunotherapy-io-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/corruption-as-an-upstream-determinant-of-global-cancer-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/framing-and-availability-of-information-regarding-alternative-cancer-therapies-by-top-us-cancer-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adolescent-and-young-adult-cancer-death-burden-in-the-united-states-from-1990-to-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-quality-4d-anatomical-and-functional-mri-for-abdominal-tumor-motion-management 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-features-and-outcomes-of-eber-negative-nasopharyngeal-carcinoma-a-large-cohort-study-acros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-clinical-pathological-tool-for-rs-prediction-a-practical-alternativ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-clinical-significance-of-pathogenic-variants-in-lynch-syndrome-a-single-center-retros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-modality-and-anatomic-site-as-determinants-of-mortality-in-second-primary-cancers-after-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-aspirin-use-on-pathological-outcomes-in-locally-advanced-rectal-cancer-patients-underg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pregnancy-and-cancer-a-retrospective-case-series-of-obstetric-oncologic-and-care-compliance-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-post-discharge-appointment-coordination-for-hospitalized-cancer-patients-utilizing-inpatie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/raced-reduction-of-cervical-cancer-disparities-racial-literacy-as-a-strategy-to-foster-a-race-cons 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reevaluating-the-comparative-effectiveness-of-glucagon-like-peptide-1-receptor-agonists-glp-1ra-vs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/representation-of-classical-and-rare-head-and-neck-cancers-in-basket-clinical-trials-a-pooled-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-immediate-and-delayed-autologous-breast-reconstruction-methods-a-retrospective-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolution-of-symptom-burden-across-prostate-cancer-disease-states-in-the-ehr-facilitated-cancer-symp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-bayesian-dose-finding-to-ai-enabled-decision-support-in-oncology-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-association-between-the-androgen-receptor-gene-polymorphisms-cag-repeats-and-aggressive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-hematologic-outcomes-in-prostate-cancer-patients-with-radiation-cystitis-receiving-hype 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-survival-and-safety-of-neoadjuvant-immune-checkpoint-inhibitors-plus-chemotherapy-in-earl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-distribution-and-clinical-impact-of-serum-tumor-marker-abnormalities-in-metastatic-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-efficacy-and-complications-of-cytoreductive-surgery-with-hipec-for-colorectal-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-effects-of-acuity-circles-policy-on-waitlist-outcomes-in-hepatocellular-carcinoma-trans 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-postoperative-adjuvant-donafenib-therapy-for-patients-with-high-risk-recu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-study-of-ds5361-a-small-molecule-nonsense-mediated-mrna-decay-nmd-inhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kandlelit-014-a-phase-2-study-of-mk-1084-as-monotherapy-and-in-combination-with-cetuximab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-exploratory-study-of-iparomlimab-and-tuvonralimab-ql1706-combined-with-bevacizumab-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/amplify-a-phase-3-study-of-sup64sup-cu-sar-bispsma-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trident-a-phase-2-study-of-relacorilant-plus-nab-paclitaxel-and-gemcitabine-in-patients-with-previo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-among-older-adults-with-coexisting-ischemic-heart-disease-and-thoracic-malignanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rna-based-next-generation-sequencing-for-identification-of-clinically-actionable-gene-fusions-missed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interrupting-sedentary-time-to-improve-cardiometabolic-health-and-toxicity-in-patients-with-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-sms-enhanced-supportive-program-to-improve-treatment-management-and-communication-during-active-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-facility-type-with-overall-survival-in-older-adults-with-angioimmunoblastic-t-cell-ly 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-evaluation-of-romiplostim-use-for-patients-with-chemotherapy-induced-thrombocytopenia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/strengthening-supportive-care-patient-guidance-oncology-models-for-adolescents-and-young-adults-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/debriefing-initiative-on-the-oncology-firm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-an-analytics-dashboard-to-measure-infusion-treatment-initiation-timelines 2026-08-24 monthly 0.7 https://rjrindex.com/articles/drivers-of-early-readmission-and-mortality-after-metastatic-spinal-cord-compression-in-cervical-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integration-of-ai-based-risk-stratified-therapy-to-optimize-outcomes-in-localized-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-specific-drivers-of-pd-1pd-l1-inhibitor-brand-preference-in-nsclc-melanoma-and-renal-cell-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-language-barriers-on-financial-toxicity-for-spanish-speaking-patients-undergoing-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progressive-locally-advanced-or-metastatic-radioiodine-refractory-differentiated-thyroid-cancer-rai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-cause-of-death-attribution-through-real-world-data-integration-a-framework-to-improve-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-enabled-analysis-of-unstructured-ehr-data-for-identification-of-actionable-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-driven-medical-oversight-in-global-oncology-trials-standardizing-immune-related-ae-manageme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-profile-and-comparative-performance-of-limited-next-generation-sequencing-and-qpcr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-quality-of-life-outcomes-in-metastatic-breast-cancer-effects-of-palliative-home-visits-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addition-of-18f-dcfpyl-psma-pet-to-mri-to-avoid-unnecessary-biopsy-in-men-on-active-surveillance-fi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-outcomes-in-pacritinib-treated-patients-with-mf-and-higher-platelet-count-my 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-capecitabine-and-trastuzumab-for-stage-ia-her2-positive-breast-cancer-iris-a-a-phase-ii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-vorasidenib-vs-placebo-on-seizure-rates-and-quality-of-life-exploratory-analysis-from-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-perioperative-pembrolizumab-in-mismatch-repair-deficientmicrosatellite-unstable-localiz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imbrave251-final-analysis-of-atezolizumab-atezo-lenvatinib-lenva-or-sorafenib-sora-vs-lenva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-analysis-of-the-ropeginterferon-alfa-2b-clinical-program-in-essential-thrombocythemia-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diverging-trends-in-head-and-neck-cancer-incidence-seer-17-analysis-of-hpv-related-and-non-hpv-rela 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-tislelizumab-combined-with-chemoradiotherapy-in-high-risk-locoregionally-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-breast-cancer-attributable-to-secondhand-smoke-in-north-american-women-a-gbd-2023-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neighborhood-level-disadvantage-and-disparities-in-treatment-and-recurrence-in-tenosynovial-giant-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-clinical-trial-enrollment-rates-among-patients-with-operable-invasive-breast-cancers-an-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-of-race-and-obesity-with-mortality-and-cardiotoxicity-in-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-exploratory-study-of-stratified-therapy-using-toripalimab-plus-gp-induction-followed-by-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-artificial-intelligence-ai-and-retrieval-augmented-generation-rag-to-identify-patient-repo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/see-her-screen-her-an-opportunistic-via-screening-and-hpv-vaccination-among-female-patient-attendan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rw-post-progression-outcomes-after-first-line-1l-treatment-with-ribociclib-an-aromatase-inhibi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-of-occupational-cancer-notification-in-brazil-2010-2024-a-15-year-national-database-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/historical-redlining-and-oral-squamous-cell-carcinoma-staging-at-diagnosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasminogen-activation-system-indices-in-basal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-and-sex-differences-in-the-incidence-of-hpv-positive-cancers-a-seer-database-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-national-health-insurance-ayushman-bharat-scheme-of-delivering-high-quality-cancer-surge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elderly-patients-with-extranodal-mzl-academic-vs-community-care-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genetic-spectrum-of-59-birt-hogg-dube-patients-in-a-single-institution-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emerging-demographic-and-geographic-disparities-in-cerebrovascular-mortality-among-us-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-characterization-and-management-of-immune-checkpoint-inhibitor-induced-pruritus-a-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/b-cell-enrollment-efficiency-program-beep-streamlining-accrual-to-early-phase-lymphoma-trials-at 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-liver-metastases-among-pancreatic-cancer-patients-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-study-of-mt-4561-in-patients-with-various-advanced-solid-tumors-nct06943521 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beamion-bcgc-1-four-new-phase-ibii-cohorts-to-evaluate-oral-zongertinib-with-other-agents-in-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-of-immunotherapy-associated-outcomes-in-patients-with-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-profile-and-treatment-outcomes-of-lymphoma-patients-a-retrospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-due-to-heart-failure-and-malignant-neoplasms-among-adult-patients-in-the-united 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-patients-comfort-with-artificial-intelligence-in-oncology-care-and-first-round-ai-chemo-tea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-trial-evaluating-anamorelin-hydrochloride-in-patients-with-gastric-cancer-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-current-sleep-cognition-evidence-and-translation-into-oncology-practice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/do-we-really-know-how-many-veterans-have-cancer-in-the-veterans-health-administration 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circadian-immune-coherence-and-readiness-as-time-aware-early-endpoints-in-a-real-world-nsclc-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-regional-trends-in-combined-colorectal-cancer-and-cerebrovascular-disease-related-mo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/afp-response-based-model-as-a-prognostic-monitor-in-unresectable-hepatocellular-carcinoma-management 2026-08-24 monthly 0.7 https://rjrindex.com/articles/becotatug-vedotin-plus-pucotenlimab-as-first-line-therapy-in-patients-with-recurrent-or-metastatic-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-ivonescimab-in-patients-with-cutaneous-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-relationship-between-event-free-and-overall-survival-in-the-era-of-perioperative-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rediscover-2-a-phase-3-study-of-zovegalisib-zovega-rly-2608-fulvestrant-fulv-versus-capivase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/forecasting-the-durability-of-overall-survival-benefit-with-gemtuzumab-ozogamicin-in-acute-myeloid-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-bayesian-methodology-in-radiopharmaceutical-therapies-dose-optimization 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-genomic-landscape-and-outcomes-of-hrd-and-hrr-alterations-in-solid-tumors-real-world-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/llc-cell-lines-response-and-resistance-to-kras-g12c-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-tumor-grade-with-increased-cd3-t-cell-and-foxp3-regulatory-t-cell-infiltration-in-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-technology-agencies-reimbursement-decisions-for-cancer-drugs-across-four-high-income-countri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thromboembolic-events-in-patients-with-advanced-non-small-cell-lung-cancer-receiving-palliative-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/coping-strategies-adopted-by-caregivers-of-pediatric-oncology-patients-navigating-the-economic-burde 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-pain-treatment-de-escalation-of-concurrent-chemoradiotherapy-combined-with-nimotuzumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unmasking-the-clinical-impact-of-sglt-2-inhibitors-in-stage-iv-colorectal-cancer-a-real-world-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-differences-in-breast-conserving-surgery-after-neoadjuvant-chemotherapy-for-her2-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-attitude-and-practices-of-residents-towards-venous-thromboembolism-prophylaxis-among-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-ecological-momentary-assessment-compliance-among-patients-with-cancer-pain 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-treatment-facility-type-on-survival-outcomes-in-elderly-patients-with-mantle-cell-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-temozolomide-nivotem-vs-temozolomide-monotherapy-in-refractory-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-center-prospective-study-evaluating-an-ai-enabled-clinical-decision-support-tool-to-improve-bi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reducing-effort-through-informatics-driven-identification-recruitment-and-data-capture-on-a-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-shr-3821-an-adcc-enhanced-cldn1824-1bb-bispecific-antibody-in-patients-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-approach-for-prediction-of-immune-related-pneumonitis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-genomic-and-clinical-predictors-of-overall-survival-and-psa-response-results-from-the-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decline-in-credit-score-and-excess-mortality-risk-among-cancer-patients-evidence-from-washington-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-ai-based-pathology-classifier-to-predict-benefit-from-enzalutamide-in-metastatic-hormone-sensitiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-distribution-and-functional-heterogeneity-of-cd56bright-and-cd56dim-natural-killer-cells-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/car-t-in-the-older-adults-real-world-survival-and-toxicity-in-patients-75-years-with-relapsedref 2026-08-24 monthly 0.7 https://rjrindex.com/articles/new-imsimwg-risk-criteria-by-next-generation-sequencing-ngs-analysis-of-daratumumab-benefit-in-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-ipik3cai-amplifications-and-co-occ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemoradiotherapy-with-or-without-pd-1-blockade-in-pmmrmss-low-rectal-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/etentamig-in-patients-pts-with-relapsedrefractory-multiple-myeloma-rrmm-with-prior-exposure-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/one-vs-2-vs-3-itet2i-mutations-in-chronic-myelomonoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-neutrophil-incompetence-following-allogeneic-stem-cell-transplant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-shallow-whole-genome-sequencing-on-diagnostic-yield-and-prognostic-precision-in-myelodyspl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lipid-lowering-therapy-use-among-cancer-survivors-undergoing-lung-cancer-screening-a-cross-sectiona 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progress-of-phase-ii-study-of-mvr-t3011-an-il-12anti-pd-1-armed-oncolytic-hsv-1-in-high-risk-bcg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-transcriptome-based-risk-modeling-improve-survival-stratification-across-cytogenetic-groups-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-and-adjuvant-neoadj-adj-enfortumab-vedotin-ev-plus-pembrolizumab-pembro-in-partici 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omitting-postoperative-radiotherapy-after-pathologic-complete-response-to-neoadjuvant-immunochemothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-shrinkage-and-depth-of-response-with-fruquintinib-in-patients-with-metastatic-colorectal-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-sosimerasib-monotherapy-in-pretreated-colorectal-cancer-with-kras-g12c-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-genomic-characterization-of-pediatric-acute-myeloid-leukemia-at-diagnosis-and-relapse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-phase-ii-trial-of-topical-betamethasone-ointment-for-preventing-severe-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-immunotherapy-for-high-risk-acute-myeloid-leukemia-and-myelodysplastic-syndrome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fine-scaled-genomic-ancestry-clusters-to-reveal-population-specific-cancer-enrichments-in-the-all-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-real-world-outcomes-of-axicabtagene-ciloleucel-axi-cel-in-relapsedrefractory-rr-larg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-digital-screening-to-increase-early-identification-of-hereditary-breast-and-ovarian-cancer-syn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-vancomycin-on-the-gut-microbiota-and-metabolic-profile-to-sensitize-microsatellite-stable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cdh6-high-gastric-cancers-as-exhibitors-of-a-reproducible-vascular-stromal-immune-excluded-tumor-mi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-costs-following-osimertinib-versus-earlier-generation-tyrosine-kinase-inhibitor-initiatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-efficiency-in-precision-oncology-quantifying-time-to-treatment-initiation-for-biomarker 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-impact-of-human-papillomavirus-vaccination-on-cervical-cancer-incidence-and-prevalence-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-chemotherapy-decision-pathways-and-survival-in-early-hrher2-breast-cancer-oncotype-dx 2026-08-24 monthly 0.7 https://rjrindex.com/articles/onkobank-a-clinically-annotated-cancer-biobank-supporting-translational-and-precision-oncology-rese 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-survival-and-persistent-age-and-sex-disparities-in-uveal-melanoma-a-seer-population-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-r0-resection-after-chemotherapy-in-initially-unresectable-metastatic-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/experimental-modeling-of-soft-tissue-sarcomas-with-invasion-into-bone-structures 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-barriers-to-prescribing-parp-inhibitors-including-olaparib-in-advanced-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-cemiplimab-fianlimab-following-sbrt-for-oligometastatic-clear-cell-rcc-lag-boos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sarc046-a-phase-ii-trial-of-nab-sirolimus-in-patients-with-progressing-or-symptomatic-epithelioid-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/causes-of-death-in-patients-with-lymphoplasmacytic-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rndo-564-001-a-first-in-human-phase-11b-study-of-rndo-564-a-costimulatory-bispecific-antibody-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-clonal-hematopoiesis-on-clinical-outcomes-in-patients-undergoing-car-t-cell-therapy-a-sys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gemini-breast-evaluating-minimal-residual-disease-mrd-through-longitudinal-circulating-tumor-dna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-comprehensive-molecular-profiling-in-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/heart-failure-related-mortality-among-us-liver-and-intrahepatic-bile-duct-cancer-patients-a-25-ye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/volrustomig-a-novel-bispecific-pd-1ctla-4-monoclonal-antibody-as-single-agent-first-line-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cctg-br38-consolidative-use-of-radiotherapy-to-block-curb2-oligoprogression-in-patients-with-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-association-of-post-testosterone-recovery-psa-kinetics-with-progression-and-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-dc-cik-plus-high-dose-interferon-a-versus-high-dose-interferon-a-alone-in-resected-stage-ii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mutational-profile-of-colorectal-cancer-cells-in-patients-with-multiple-primary-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pact-chemo-improving-chemotherapy-flow-safety-and-value-through-physician-pharmacist-ehr-activati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/methylation-pipeline-to-accurately-detect-cpg-methylation-status 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-study-of-allostatic-load-area-deprivation-and-race-in-endometrioid-endometrial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-clinical-evaluation-of-st-01156-an-optimized-and-selective-degrader-of-rna-binding-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethan-a-phase-ii-study-comparing-different-endocrine-therapies-for-male-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-and-protective-factors-for-acral-mucosal-and-uveal-melanoma-in-a-multi-institutional-cohort-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-after-stereotactic-radiosurgery-for-brain-metastases-in-renal-cell-carcinoma-a-con 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-socioeconomic-and-geographic-disparities-in-survival-among-patients-with-ampullary-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/parp-inhibitor-and-immune-checkpoint-inhibitor-combination-therapy-in-pd-l1-negative-tumors-a-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-preoperative-breast-mri-on-locoregional-staging-and-management-in-early-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-statins-on-outcomes-in-renal-cell-carcinoma-patients-undergoing-immune-checkpoint-inhibito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-tolerability-of-talimogene-laherparepvec-in-treatment-of-solid-tumors-a-systematic-rev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-bladder-cancer-across-asia-insights-from-the-global-burden-of-disease-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-integrated-population-pharmacokineticpharmacodynamic-poppkpd-model-to-select-the-linvoseltama 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-asynchronous-time-flexible-digital-multidisciplinary-care-with-overall-survival-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-clinical-outcomes-among-cholangiocarcinoma-patients-treated-with-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibody-drug-conjugate-adc-after-adc-predicting-survival-in-patients-with-her2-low-metastatic-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rp2r-dose-selection-of-tal-tec-for-the-treatment-of-emd-patients-in-the-redirectt-1-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-characteristics-of-patients-with-minimal-residual-disease-in-stage-ii-iii-colon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spark-lung-a-study-of-patterns-and-outcomes-in-young-onset-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/natural-language-processing-chatbot-and-continuous-activity-monitoring-in-a-phase-ii-randomized-tria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-innovative-team-approach-to-improve-sclc-care-across-an-integrated-health-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-chemo-induced-tme-alterations-as-a-predictor-of-response-to-pd-1-blockade-in-avpc-single-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-circulating-tumor-cell-genomics-of-kras-independent-oncogenic-sub-populations-and-longit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/estimating-individual-benefit-from-adjuvant-chemotherapy-in-hormone-receptor-positive-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-corticosteroid-exposure-on-long-term-immune-checkpoint-inhibitor-responses-in-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/punch03-preliminary-results-from-a-phase-ii-study-of-disitamab-vedotin-combined-with-tislelizumab-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-overall-survival-safety-and-neurologic-function-outcomes-from-a-phase-1-trial-of-bivalent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lucicebtide-st101-plus-chemoradiation-in-newly-diagnosed-gbm-patients-efficacy-pharmacodynamics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-endovascular-embolization-in-cancer-associated-gastrointestinal-bleeding-a-nationwide-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-imaging-detected-extranodal-extension-iene-in-pathological-ene-negative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-bispecific-antibody-ivonescimab-based-regimens-in-egfr-tki-resista 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gt101-autologous-til-therapy-in-patients-with-recurrent-and-metastatic-cervical-cancer-a-phase-1-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neighborhood-social-vulnerability-and-clinical-trial-enrollment-in-colon-cancer-does-age-matter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hospital-designation-and-survival-disparities-in-young-onset-gastrointestinal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-tarlatamab-in-extensive-stage-small-cell-lung-cancer-a-single-cen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/balancing-effectiveness-and-toxicity-cabozantinib-versus-belzutifan-after-icivegf-therapy-in-older 2026-08-24 monthly 0.7 https://rjrindex.com/articles/maintenance-therapy-and-treatment-holiday-in-patients-with-unresectablelocally-advancedmetastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/folfirinox-vs-gempac-in-the-elderly-is-the-survival-benefit-worth-the-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-tiger-pac-phase-3-clinical-trial-examining-intra-arterial-gemcitabine-versus-intravenous-gemcita 2026-08-24 monthly 0.7 https://rjrindex.com/articles/synergistic-efficiency-of-methylene-blue-and-carbon-nanoparticles-for-sentinel-lymph-node-biopsy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-an-endometrial-cancer-test-from-a-vaginal-swab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-deruxtecan-in-patients-with-her2-low-recurrentmetastatic-salivary-gland-carcinoma-resu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shr-1826-a-c-met-directed-antibody-drug-conjugate-adc-in-advanced-solid-tumors-updates-from-a-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dose-escalation-results-from-a-phase-i-study-of-fz-ad004-a-trop2-directed-adc-in-patients-with-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-human-b7h3il13ra2-bispecific-armored-car-t-for-treatment-of-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emotional-health-concerns-due-to-kidney-cancer-kc-and-unmet-needs-in-patient-support-results-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stage-i-results-of-a-phase-ii-study-evaluating-thymosin-a1-combined-with-toripalimab-in-elderly-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neighborhood-disadvantage-and-correlation-with-differences-in-somatic-mutations-in-a-real-world-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-profiling-of-egfr-pacc-mutations-and-their-co-mutation-landscape-in-chinese-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-ten-year-survival-with-cell-free-dna-methylation-of-melanoma-patients-with-asymptomat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-utilization-patterns-and-adverse-events-among-patients-receiving-antibody-drug-conjugates 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overcoming-her2-directed-antibody-drug-conjugate-resistance-with-disitamab-vedotin-in-metastatic-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-of-lb1410-a-bivalent-tim-3pd-1-bispecific-antibody-in-combination-with-lb4330-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-effects-of-tgf-v-inhibition-on-immune-resistance-by-targeting-immunosuppressive-microenvir 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rural-urban-disparities-in-musculoskeletal-functional-limitation-among-cancer-patients-in-the-united 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-therapy-associated-differences-in-intracranial-disease-in-metastatic-prostate-cancer-a-rea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/taxane-based-chemotherapy-with-or-without-platinum-agents-in-metastatic-castration-resistant-prostat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inspiring-the-next-generation-of-medical-oncologists-passion-purpose-and-preventing-burnout 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-surgical-timing-on-outcomes-in-patients-with-borderline-resectable-and-locally-advanced-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reduction-in-circulating-tumor-dna-ctdna-in-relation-to-radiographic-response-and-tumor-pd-l1-expr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/construction-and-validation-of-a-prognostic-risk-model-for-lung-adenocarcinoma-based-on-pyroptosis-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uncertainty-aware-ai-triage-for-luad-histologic-subtyping-flagging-cases-for-expert-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-younger-patients-considered-geographic-access-and-age-focused-design-in-advanced-pdac-trials-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omic-profiling-to-clarify-mechanisms-of-therapy-induced-prostate-cancer-lineage-plasticity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-antibiotic-exposure-and-outcomes-of-immune-checkpoint-inhibitors-in-non-small-cell-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-lifileucel-in-advanced-melanoma-a-single-institution-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-risk-factors-for-pneumonitis-in-patients-with-urothelial-carcinoma-treated-with-enfort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/etctn-10302-a-randomized-phase-ii-trial-of-radium-223-dichloride-in-combination-with-paclitaxel-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-class-dio3-inhibitor-as-a-novel-treatment-strategy-in-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-the-tumor-microbiology-and-microenvironment-of-patients-with-triple-negative-inflammatory 2026-08-24 monthly 0.7 https://rjrindex.com/articles/persistence-of-aggressive-biology-outcomes-of-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epigenetic-state-control-and-immune-visibility-as-prognostic-modules-in-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-accessibility-of-recruiting-clinical-trials-for-rare-and-common-gastrointestinal-malignan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-diversity-and-composition-of-sulfidogenic-gut-bacteria-in-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/closing-the-information-gap-in-oncology-a-retrieval-augmented-generation-multi-modal-ai-platform-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/latent-transitions-of-distress-risk-during-cancer-treatment-and-their-concordance-with-anxiety-depr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-severity-and-management-of-severe-adverse-events-in-first-line-1l-treatments-for-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-representation-in-clinical-trials-supporting-nccn-breast-cancer-guidelines-a-retrospective-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alkove-1-efficacy-and-safety-of-neladalkib-in-patients-with-advanced-ialki 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-aav6-neurod1-trans-differentiation-therapy-in-recurrent-malignant-glioma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-use-of-circulating-tumor-dna-to-stratify-the-risk-of-recurrence-after-surgical-debulking-in-epit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-two-year-overall-survival-and-toxicity-outcomes-of-bcma-car-t-therapy-compared-with-teclista 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-lenvatinib-plus-pembrolizumab-in-patients-pts-with-endometrial-or-ovarian-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-prophylactic-effects-for-chemotherapy-induced-neutropenia-between-same-day-versus-next 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-feasibility-of-outpatient-administration-of-targeted-alpha-therapies-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunonutrition-intervention-in-driver-gene-negative-non-small-cell-lung-cancer-patients-with-sarcop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-results-of-the-phase-2-study-of-silevertinib-bdtx-1535-in-previously-treated-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-ipilimumab-combined-with-chemotherapy-as-first-line-treatment-for-her2-negative-unres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-barriers-to-the-clinical-breast-exam-in-telangana-india-a-survey-study-of-participan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-pathologic-complete-response-following-neoadjuvant-tchp-in-her2-positive-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-results-of-neoadjuvant-therapy-with-pyrotinib-subcutaneous-trastuzumab-and-capecitabine-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/herthena-breast04-a-phase-3-randomized-open-label-study-evaluating-the-efficacy-and-safety-of-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinico-transcriptomic-risk-stratification-to-guide-abiraterone-treatment-intensification-in-high-ri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-status-and-tarlatamab-outcomes-in-a-large-multi-institution-real-world-database-of-2l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-progression-discontinuation-and-off-treatment-progression-free-interval-after-enfortumab-vedotin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-incidence-of-hypothyroidism-and-thyroiditis-after-car-t-cell-therapy-versus-standard-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ugt1a1-status-and-clinical-outcomes-in-pancreatic-cancer-patients-receiving-liposomal-irinotecan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-perioperative-use-of-tislelizumab-in-treating-clinically-node-positive-urothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-clonal-plasma-cell-s-phase-after-autologous-stem-cell-transplantation-and-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alfa-score-as-a-predictor-of-long-term-benefit-with-frontline-brigatinib-in-ia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-accelerated-partial-breast-irradiation-simultaneous-integrated-boost-technique-rush-experienc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-pfs-in-third-line-immune-checkpoint-inhibitor-resistant-advanced-nsclc-treated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/paired-nectin4-expression-analysis-pre-and-post-enfortumab-vedotin-and-pembrolizumab-in-urothelial-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-biomarker-analysis-of-ociperlimab-oci-plus-tislelizumab-tis-in-patients-pts-with-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benefits-of-utilizing-experiential-learning-in-a-medical-school-cancer-survivorship-course 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-neoadjuvant-toripalimab-combined-with-temozolomide-in-resectable-stage-ii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/career-destination-effects-of-receipt-of-the-american-society-of-clinical-oncology-young-investigato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-baseline-gut-microbiome-features-between-response-subgroups-of-patients-pts-with-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-rpl37-on-the-proliferation-migration-and-invasion-of-non-small-cell-lung-cancer-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-mrd-positivity-at-ultra-sensitive-ctdna-levels-using-a-wgs-based-personalized-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ibi3017-an-innovative-bispecific-anti-trop2-and-b7h3-antibody-drug-conjugate-on-anti-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/urinary-rna-as-response-predictor-for-patients-with-metastatic-urothelial-carcinoma-treated-with-pem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hybrid-ai-framework-for-automated-prostate-cancer-disease-state-ascertainment-from-real-world-electr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-lymphovascular-invasion-in-breast-carcinoma-using-mri-based-radiomics-a-systematic-re 2026-08-24 monthly 0.7